Welex Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.60 M
- Company Age 45 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 Cr
- Satisfied Charges ₹ 1.11 Cr
- Revenue Growth -0.50%
- Profit Growth -75.24%
- Ebitda -13.99%
- Net Worth 0.85%
- Total Assets 1.71%
About Welex Laboratories
Welex Laboratories Private Limited (WLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 June 1979 and has a history of 45 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹2.30 Cr. The company has closed loans amounting to ₹1.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
Roopam Bhatt and Priya Roopam serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH1979PTC021411
- Company No.
021411
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 1979
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Welex Laboratories Private Limited offer?
Welex Laboratories Private Limited offers a wide range of products and services, including Popular Category, Stomach Care, Diabetic Medicines, Ayurvedic Medicines, Liver Care, Health Conditions, Kidney Care, Sexual Wellness, Men Performance Enhancers, Pain Relief.
Who are the key members and board of directors at Welex Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roopam Bhatt  | Managing Director | 10-Sep-1997 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priya Roopam | Director | 06-Jan-2007 | Current |
Financial Performance of Welex Laboratories.
Welex Laboratories Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.5% decrease. The company also saw a substantial fall in profitability, with a 75.24% decrease in profit. The company's net worth moved up by a moderate rise of 0.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Welex Laboratories?
In 2023, Welex Laboratories had a public holding of 11.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayuwelex Private LimitedRoopam Bhatt and Priya Roopam are mutual person
Charges (Loans)
₹22.95 M
₹11.12 M
Charges Breakdown by Lending Institutions
- Dena Bank : 2.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 1993 | Dena Bank | ₹3.10 M | Open |
| 26 Jul 1993 | Dena Bank | ₹1.99 Cr | Open |
| 05 Jul 2017 | Others | ₹5.00 M | Satisfied |
| 06 Aug 2008 | The Saraswat Co-Op Bank Ltd | ₹4.50 M | Satisfied |
| 17 Oct 1990 | Bank Of Baroda | ₹0.38 M | Satisfied |
How Many Employees Work at Welex Laboratories?
Welex Laboratories has a workforce of 37 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welex Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.